References 1 Brandling-Bennett HA, Morel KD. Epidermal nevi. Pediatr Clin North Am 2010; 57: 1177–1198. 2 Ichikawa T, Saiki M, Kaneko M, et al. Squamous cell carcinoma arising in a… Click to show full abstract
References 1 Brandling-Bennett HA, Morel KD. Epidermal nevi. Pediatr Clin North Am 2010; 57: 1177–1198. 2 Ichikawa T, Saiki M, Kaneko M, et al. Squamous cell carcinoma arising in a verrucous epidermal nevus. Dermatology 1996; 193: 135–138. 3 Zheng LQ, Huang Y, Qu YJ, et al.Multiple basal cell carcinomas arising in a verrucous epidermal nevus. J Dermatol 2013; 40: 482–483. 4 Jeon J, Kim JH, Baek YS, et al. Eccrine poroma and eccrine porocarcinoma in linear epidermal nevus. Am J Dermatopathol 2014; 36: 430–432. 5 Miranda LQ, Fracaroli TS, Fonseca JC, et al. Analysis of mutations in the PIK3CA and FGFR3 genes in verrucous epidermal nevus. An Bras Dermatol 2013; 88: 36–38. 6 Levinsohn JL, Teng J, Craiglow BG, et al. Somatic HRAS p. G12S mutation causes wooly hair and epidermal nevi. J Invest Dermatol 2014; 134: 1149–1152. 7 Schubbert S, Shannon K, Bollag G. Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer 2007; 7: 295–308. 8 Hafner C, Toll A, Real FX. HRAS mutation mosaicism causing urothelial cancer and epidermal nevus. N Engl J Med 2011; 365: 1940–1942. 9 Hafner C, Toll A, Gantner S, et al. Keratinocytic epidermal nevi are associated with mosaic RAS mutations. J Med Genet 2012; 49: 249–253. 10 Georgieva A, Mauerer A, Groesser L, et al. Low incidence of oncogenic EGFR, HRAS, and KRAS mutations in seborrheic keratosis. Am J Dermatopathol 2014; 36: 635–642.
               
Click one of the above tabs to view related content.